THA analogs useful as cholinesterase inhibitors

Details THA analogs useful as cholinesterase inhibitors THA analogs useful as cholinesterase inhibitors

1995-12-11

1998-07-21

Rotman, Alan L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546 97, A61K 3144, C07D21912

Patent

active

057835845

ABSTRACT:
The present invention provides cholinesterase inhibitors of general formula (I): ##STR1## wherein R is H or (C.sub.1 -C.sub.4)alkyl, Y is a linking group and Z is an alkyl or aryl group, including heteroaryl groups, and the pharmaceutically acceptable salts thereof.

REFERENCES:
patent: 4631286 (1986-12-01), Shutske et al.
patent: 4816456 (1989-03-01), Summers
patent: 5026897 (1991-06-01), Chiang et al.
patent: 5104880 (1992-04-01), Kozikowski
Teh Kuei Chen, et al., "Diacridines, Bifunctional INtercalators. Chemistry and Antitumor Activity", J. Med. Chem., 21, 868-874, (1978).
Kenneth L. Davis, et al., "Tacrine", The Lancet, 345, 625-630, (1995).
Dimitrios Galanakis, et al., "Synthesis and Structure--Activity Relationships of DeQualinium Analogues as K+ Channel Blockers. Investigations on the Role of the Charged Heterocycle", J. Med. Chem., 38, 595-606, (1995).
M. Harel, et al., "Conversion of Acetylcholinesterase to Butyrylcholinesterase: Modeling and Mutagenesis", Proc. Natl. Acad. Sci. USA, 89, 10827-10831, (Nov. 1992).
C. M. Himel, et al., "Acidine Araphanes: A New Class of Probe Molecules for Biological Systems", Science, 205, 1277-1279, (1979).
Zaven S. Khachaturian, "Diagnosis of Alzheimer's Diseasae", Arch. Neurol., 42, 1097-1105, (1985).
Mark E. Nelson, et al., "9-Aminoacridines Act at a Site Different from that for Mg2+ in Blockade of the N-Methyl-D-Aspartate Receptor Channel", Mol. Pharmacol., 46, 151-160, (1994).
J. Patocka, et al., "Kinetics of Inhibition of Cholinesterases by 1,2,3,4-Tetra-Hydro-9-Aminoacridine in vitro", Collect. Czech. Chem. Commun., 41, 816-824, (1976).
Dennis J. Selkoe, "The Molecular Pathology of Alzheimer's Disease", Neuron, 6, 487-498, (1991).
Rudolph Tanzi, et al., "Genetic Heterogeneity of Gene Defects Responsible for Familial Alzheimer's Disease", Genetica, 91, 255-263, (1993).
Jeffrey L. Taylor, et al., "Conformers of Acetylcholinesterase: A Mechanism of Allosteric Control", Mol. Pharmacol., 45, 74-83, (1994).
I. B. Wilson, et al., "A Power Reactivator of Alkylphosphate-Inhibited Acetylcholinesterase", Biochim. Biophys. Acta, 18, 168-170, (1955).
Bindra, J.S., et al., "Synthesis, Pharmacological Activities & Physico-chemical Properties of 4-(Substituted amino/N.sup.4 -arylpiperazinyl/aminocarbonyl)-2,3-polymethylenequinolines", Indian Journal of Chemistry, vol. 26B, pp. 318-329 (Apr. 1987).
Pang, Y., et al., "Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase", The Journal of Biological Chemistry, vol. 271, No. 39, pp. 23646-23649 (Sep. 27, 1996).
Rastogi, S.N., et al., "Local Anaesthetic Activity of 9-Alkylamino-1,2,3,4-Tetrahydroacridines: Structure-Activity Relationship Study", Indian Journal of Pharmacology, 19, pp. 44-48 (1987).
Steinberg, G.M., et al., "A Hydrophobic Binding Site in Acetylcholinesterase", Journal of Medinicinal Chemistry, vol. 18, No. 11, pp. 1056-1061 (May 12, 1975).

Affiliated with

Also associated with

Rating

THA analogs useful as cholinesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with THA analogs useful as cholinesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and THA analogs useful as cholinesterase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1647335